As of 2025-12-31, the Intrinsic Value of Vor Biopharma Inc (VOR) is -805.12 USD. This VOR valuation is based on the model Peter Lynch Fair Value. With the current market price of 12.53 USD, the upside of Vor Biopharma Inc is -6,525.50%.
Based on its market price of 12.53 USD and our intrinsic valuation, Vor Biopharma Inc (VOR) is overvalued by 6,525.50%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -805.12 - -805.12 | -805.12 | -6,525.50% |
| P/E | (2,647.22) - (2,805.02) | (2,697.14) | -21625.5% |
| DDM - Stable | (1,889.72) - (9,114.32) | (5,502.02) | -44010.8% |
| DDM - Multi | (1.51) - (5.42) | (2.33) | -118.6% |
| Market Cap (mil) | 190.61 |
| Beta | 6.46 |
| Outstanding shares (mil) | 15.21 |
| Enterprise Value (mil) | 30.15 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.78% |
| Cost of Debt | 5.00% |
| WACC | 5.72% |